The USA cataract surgery devices market is one of the most advanced and competitive healthcare technology sectors in the world, driven by a blend of aging demographics, high urbanization, and rapid adoption of innovative ophthalmic technologies. The demand for cataract surgery devices has grown steadily as the aging population continues to expand and as more people seek to maintain visual clarity and independence into later life. The country has a culture of embracing cutting-edge technologies, which extends to healthcare and ophthalmology. Medical device manufacturers in the U.S. are continuously introducing new product lines with advanced optics, improved surgical precision, and better patient outcomes. The regulatory environment is stringent but also promotes quality assurance, which helps maintain patient confidence and drives long-term demand. Additionally, Americans are increasingly aware of elective and cosmetic eye treatments, viewing cataract surgery not just as a necessity but also as a vision enhancement opportunity.

This mindset has encouraged companies to focus on both functional and lifestyle-oriented marketing promoting devices that not only remove cataracts but also correct vision problems like presbyopia and astigmatism. Economically, the U.S. market is characterized by a mix of public and private healthcare systems, with Medicare covering a significant portion of cataract surgeries. However, premium lens options and laser-assisted procedures often fall outside standard insurance coverage, creating a growing self-pay segment where consumers invest in premium outcomes. This balance between clinical necessity and elective spending fuels both volume and profitability in the market. According to the research report "USA Cataract Surgery Devices Market Research Report, 2030," published by Actual Market Research, the USA Cataract Surgery Devices market is anticipated to grow at 3.81% CAGR from 2025 to 2030. The U.S. has one of the world’s largest aging populations, with millions of people over the age of 60 a group highly susceptible to cataracts. However, unlike in developing regions, older adults in the U.S. are proactive about healthcare and possess better access to medical insurance, making them more likely to opt for surgery rather than live with declining vision. The widespread presence of specialized ophthalmic centers, well-established healthcare infrastructure, and skilled surgeons further encourages this demand.

The increasing preference for ambulatory surgical centers (ASCs) over traditional hospital settings is another key trend. These centers offer faster, more cost-efficient cataract surgeries, appealing to patients who want minimal downtime and high-quality results. This shift has created opportunities for device manufacturers to design compact, easy-to-use systems tailored for outpatient environments. The U.S. is home to some of the world’s leading ophthalmology research hubs, such as those in Boston, Houston, and San Francisco, where innovation in laser technology and IOL materials is most active. Moreover, consumer attitudes in the U.S. lean heavily toward quality and lifestyle enhancement, making premium cataract surgery options more popular than in most other regions. Seasonal health events like “Healthy Vision Month” and campaigns led by the American Academy of Ophthalmology also keep public attention focused on vision care.

Combined with high disposable income, tech-driven healthcare marketing, and increasing digital health literacy, these factors continue to open new growth avenues.Intraocular lenses (IOLs) represent the largest and most rapidly evolving category, driven by a high volume of cataract procedures and a growing demand for premium lenses that correct presbyopia and astigmatism. American patients increasingly opt for advanced multifocal and toric IOLs, supported by private insurance and Medicare reimbursements, which encourage the use of high-value products. Phacoemulsification systems, which use ultrasonic energy to emulsify and remove the cataract, remain a cornerstone of surgical practice in the U.S. With brands like Alcon’s Centurion and Johnson & Johnson’s WHITESTAR Signature Pro, the country leads in adopting systems that offer better fluidics control, lower energy usage, and improved incision stability. Ophthalmic viscoelastic devices (OVDs)—essential for maintaining anterior chamber depth and protecting ocular tissues—see consistent demand from hospitals and ambulatory surgery centers (ASCs), with U.S.-made viscoelastics favored for their purity and biocompatibility. Femtosecond laser systems, though costlier, are gaining momentum due to their precision and role in premium surgeries, especially in urban centers where high-income patients seek bladeless cataract procedures.

Meanwhile, other devices, including surgical knives, forceps, and low-cost consumables, ensure accessibility across smaller clinics and government programs.Hospitals account for a major share due to their comprehensive infrastructure, access to advanced diagnostic tools, and ability to perform complex or high-risk surgeries, often covered by Medicare and private insurance. However, the trend is shifting toward ambulatory surgery centers, which now perform over two-thirds of cataract procedures in the U.S. due to their efficiency, lower costs, and shorter recovery times. ASCs are equipped with modern phaco and laser systems, offering a balance between cost-effectiveness and high-quality outcomes. Ophthalmology clinics cater to routine cataract surgeries and follow-up care, contributing significantly to device demand for diagnostic and minor surgical tools. Meanwhile, academic and research institutes play a critical role in testing new technologies, training ophthalmic surgeons, and supporting clinical trials for next-generation lenses and lasers. U.S. universities and institutions such as the Wilmer Eye Institute and Bascom Palmer Eye Institute collaborate with manufacturers to advance precision surgery and implant design.

The strong interplay between these end-user categories supported by government reimbursement programs, private investments, and clinical innovation ensures that cataract surgery in the U.S. remains highly efficient, accessible, and technologically advanced.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cataract Surgery Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Intra-ocular Lenses (IOL)• Phacoemulsification Systems• Ophthalmic Viscoelastic Devices• Femtosecond Laser Systems• Others (Knives and Low-Cost Consumables)By End User• Hospitals• Ambulatory Surgery Centers• Ophthalmology Clinics• Academic and Research Institutes.